02:00
This post hoc analysis of A Study to Evaluate the Corvia Medical Inc IASD System II to Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (REDUCE LAP-HF II) randomized clinical trial evaluates the long-term effects of an atrial shunt device on cardiac structure and function in (…)
02:00
In this issue of JAMA Cardiology, Li et al report the results of the double-blind, placebo-controlled Optimal Antiplatelet Therapy for High Bleeding and Ischemic Risk Patients (OPT-BIRISK) trial, which randomized 7758 patients with acute coronary syndrome (ACS) after percutaneous coronary (…)
02:00
Atrial fibrillation (AF) and heart failure (HF) coexist in a syndemic relationship, characterized by a similar epidemiology and exacerbated pathological outcomes, often intensified by social drivers of health. The 2023 ACC/AHA/ACCP/HRS Guidelines for the Diagnosis and Management of Atrial (…)
02:00
Mission Statement:? JAMA Cardiology is positioned at the nexus of clinical investigation, actionable clinical science, and clinical practice, with emphasis on traditional cardiovascular medicine, evolving cardiovascular science, and evidence-based health policy. Health equity, especially when (…)
02:00
The Original Investigation titled “Emphasizing Sexual Orientation and Gender Identity Data Capture for Improved Cardiovascular Care of the LGBTQ+ Population,” published online January 24, 2024, and in the March 2024 issue of JAMA Cardiology, was corrected to fix an error in the categorization of (…)
02:00
This cohort study explores whether a novel artificial intelligence (AI) video-based biomarker for aortic stenosis is associated with development and progression of aortic stenosis.
02:00
This cohort study investigates the association of clonal hematopoiesis of indeterminate potential with risk for atrial fibrillation.
02:00
This secondary analysis of a randomized clinical trial examines the antibody response to high-dose trivalent compared with standard-dose quadrivalent inactivated influenza vaccine in patients with a recent acute myocardial infarction or heart failure hospitalization.
02:00
This randomized clinical trial evaluates clopidogrel monotherapy vs dual antiplatelet therapy in patients with acute coronary syndromes undergoing percutaneous coronary interventions who are at high bleeding and ischemic risk.
02:00
This case report discusses a diagnosis of Leriche syndrome in a male patient with peripheral arterial disease, erectile dysfunction, and nonischemic cardiomyopathy.
02:00
This cohort study evaluates recent reversals in declines in cardiovascular mortality and whether they vary across sociodemographic categories.
02:00
This systematic review and meta-analysis investigates the efficacy of catheter ablation compared with rate or rhythm control among patients with atrial fibrillation and heart failure.
02:00
This Viewpoint discusses the impact of sinus node dysfunction and escape junctional rhythm associated with the Fontan procedure on patient outcomes.
02:00
This cross-sectional study investigates the association between cardiometabolic disease prevalence in the US and deep learning–based assessment of the built environment from satellite imagery.
02:00
A woman in her mid-60s with a history of paroxysmal atrial fibrillation and hypertension presents with 3 days of nausea, vomiting, and diarrhea. What would you do next?
02:00
This randomized clinical trial investigates if patients with high bleeding risk and a history of myocardial infarction (MI) would benefit from complete vs culprit-only revascularization.
02:00
This Viewpoint discusses the unequal representation of women in coronary revascularization trials in the US, its negative effects on the cardiovascular health of both sexes, and potential mechanisms to ensure appropriate representation of women moving forward.